In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Source: [New York Times](https://www.nytimes.com/2026/08/26/science/pancreatic-cancer-daraxonrasib-approval.html)

Sponsored